1 / 38

Fibrin Glue for Pterygium Surgery

Fibrin Glue for Pterygium Surgery. Sathish Srinivasan FRCSEd, FRCOphth Consultant Ophthalmologist Ayr Hospital, Ayr Scotland, UK. No financial interest. Introduction Chemical composition How to mix How to apply Results. A two-component fibrin sealant.

amena
Download Presentation

Fibrin Glue for Pterygium Surgery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fibrin Glue for Pterygium Surgery Sathish Srinivasan FRCSEd, FRCOphth Consultant Ophthalmologist Ayr Hospital, Ayr Scotland, UK

  2. No financial interest

  3. Introduction • Chemical composition • How to mix • How to apply • Results

  4. A two-component fibrin sealant. • Contains two of the protein that makes the blood clot. • Fibrinogen and thrombin

  5. SEALANT PROTEIN: solution composed of Human fibrinogen, plasminogen, fibronectin and Factor XIII reconstituted in a Bovine aprotinin solution • SEALANT SETTING: solution composed of Human thrombin reconstituted in a calcium chloride solution

  6. Simulates Physiological Clotting Plasma clot Tisseel A non-physiologic sealant

  7. What can you do with Tisseel? • Control intra-operative bleeding • Prevent post-operative haemorrhage • Repair leaks including CSF • Prevent post-op leakage including CSF • To promote tissue adhesion • To support a suture line

  8. Fibrin Glue CAN…. • Complement good surgical haemostatic techniques, such as • Ligatures or sutures • Clips or staples • Electrocautery • Provide a water or fluid-tight seal CANNOT…. • Stop arterial bleeding • Stop severe venous bleeding

  9. Clinical experience with Tisseel • No documented transmission of: • HIV, Hepatitis B, Hepatitis C • Over 33 years of use in many countries • Available in 50 countries worldwide • More than 17 million applications to date • 3500+ publications in most surgical disciplines Data on file, Baxter Healthcare

  10. Tisseel Kit has 4 components • 1 vial: Sealer protein lyophilized concentrate. • 1 vial: Lyophilized human thrombin. • 1 vial: Aprotinin solution. • 1 vial: Calcium chloride solution.

  11. What's in it • When reconstituted 1 ml of each solution contains: • Human Fibrinogen: 72-110 mg in 96-125 mg protein, aprotinin (bovine) 3000 KIU/ml. Inactive ingredients include human albumin, L-Histidine, niacinamide, polysorbate 80 and sodium citrate.

  12. Human thrombin 5 or 500 IU, in 45-55 mg protein, calcium chloride 40 micromoles/ litre. Inactive ingredients include human albumin and sodium chloride.

  13. Human plasma pools are tested for presence of genome sequences of HIV, HBV and HCV • Tisseel is vapor-heated to inactivate viruses • No evidence of disease transmission yet • What about prions in Bovine aprotinin

  14. Pharmacokinetics • Tisseel is intended for epilesional use only. • Intravascular pharmacokinetic studies have not been performed in humans. • Fibrin sealants are metabolized in the same way as endogenous fibrin – fibrinolysis and phagocytosis.

  15. Contraindications • Not for intravascular use. Carries a high risk of thromboembolic complications. • Remember it has a bovine protein (aprotinin) : risk of anaphylactic reaction. • Risk is slightly higher in cases of previous exposure.

  16. CASE 2: POSTOP DISLOCATION OF CONJUNCTIVAL GRAFT Eye, 2007

  17. Fibrin Glue versus Sutures for attaching the Conjunctival Autograft in Pterygium Surgery: A Prospective Observer Masked Clinical Trial Sathish Srinivasan FRCSEd, FRCOphth Michael Dollin MD Penny McAllum FRANZCO Yoav Berger MD David S. Rootman MD, FRCSC Allan R. Slomovic MD, FRCSC

  18. Table 1. Scoring parameters for each of the three outcome variables

More Related